SHANGHAI, China, July 9 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today proudly announced that Ms. Trabue D. Bryans, Vice President and General Manager of WuXi AppTec's Atlanta Operations, one of the U.S. operating subsidiaries of WuXi PharmaTech (Cayman) Inc., has been invited to join the Association for the Advancement of Medical Instrumentation (AAMI) Standards Board for a three-year term.
Founded in 1967, the non-profit AAMI is a unique alliance of over 6,000 individuals and 375 organizations from around the world united by the common goal of increasing the understanding and beneficial use of medical instrumentation, as well as the primary resource for the industry, professions, and government for national and international standards. The AAMI standards program consists of over 100 technical committees and working groups that produce Standards, Recommended Practices, and Technical Information Reports for medical devices. Standards and Recommended Practices represent a national consensus and many have been approved by the American National Standards Institute (ANSI) as American National Standards as well as International Standardization Organization (ISO) standards.
Having served as a member of AAMI Sterilization Standards Committee, former co-chair of the AAMI Microbiological Methods Working Group, and expert member to the ISO TC 198 Micro Methods working group, Ms. Bryans will work regularly with more important responsibilities in her new role of directing and supervising all AAMI technical committee activities relating to the national standards program.
''I am very honored to be part of the national standards program, and
|SOURCE WuXi PharmaTech (Cayman) Inc.|
Copyright©2008 PR Newswire.
All rights reserved